03/29/2022
AZTherapies: Harnessing the power of Neuro-Immunology
A Company overview of AZTherapies & Its Pipeline Due to neurodegenerative diseases, more than 10 million people in the US suffer from a cognitive and physical impairment. AZTherapies, Inc. is on a mission to improve the lives of these 10 million people through neuroimmunology. A private clinical-stage biopharmaceutical company, AZTherpaies, is headquartered in Boston, Massachusetts….
Keep Reading
